EMPLOYING LI-RADS ON DYNAMIC MRI SCANS FOR DISTINGUISHING HEPATOCELLULAR CARCINOMA FROM OTHER HEPATIC FOCAL LESIONS IN HIGH RISK PATIENTS

heba ellaban, Rasha Aly, Sameh Abokoura
{"title":"EMPLOYING LI-RADS ON DYNAMIC MRI SCANS FOR DISTINGUISHING HEPATOCELLULAR CARCINOMA FROM OTHER HEPATIC FOCAL LESIONS IN HIGH RISK PATIENTS","authors":"heba ellaban, Rasha Aly, Sameh Abokoura","doi":"10.21608/asmj.2023.321826","DOIUrl":null,"url":null,"abstract":": Background: LI-RADS (Liver Imaging Reporting and Data System) provide standardization for screening high risk patients for hepatocellular carcinoma (HCC). Moreover, it aids in treatment response assessment. HCC is special among different malignancies in having tumor hallmark on dynamic CT or MRI that permit accurate diagnosis without an invasive biopsy. Objective: To appraise LI-RADS on dynamic MRI scans for distinguishing hepatocellular carcinoma from other hepatic focal lesions in high risk patients. Patients and methods: This study was designed in a retrospective pattern. It included eighty five high risk patients for hepatocellular carcinoma who had undergone dynamic MRI scans. Dynamic MRI scans were evaluated using LI-RADS features for distinguishing hepatocellular carcinoma from other hepatic focal lesions. Eventually, the obtained results were correlated with serial imaging follow - up or histopathological diagnosis as the diagnostic standard of reference. Results: The majority of the included patients were found to have malignant lesions (67.1%) predominantly HCC (45.9%), followed by cholangiocarcinoma (8.2%) and finally hepatic deposits (7.1%). Considering LI-RADS categorization, hemangioma was most common among LIRAD1 group (60%), regeneration nodule among LIRAD 2 group (88.9%), dysplastic nodule among both LIRAD3 (50%) and LIRAD 4 groups (55.6). HCC among LIRAD5 group (100%). Finally, cholangiocarcinoma among LRM group (53.8 %). Conclusions: Employing LI-RADS on dynamic MRI scans for distinguishing hepatocellular carcinoma from other hepatic focal lesions in high risk patients improves patient management","PeriodicalId":7450,"journal":{"name":"Ain Shams Medical Journal","volume":"48 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ain Shams Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/asmj.2023.321826","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

: Background: LI-RADS (Liver Imaging Reporting and Data System) provide standardization for screening high risk patients for hepatocellular carcinoma (HCC). Moreover, it aids in treatment response assessment. HCC is special among different malignancies in having tumor hallmark on dynamic CT or MRI that permit accurate diagnosis without an invasive biopsy. Objective: To appraise LI-RADS on dynamic MRI scans for distinguishing hepatocellular carcinoma from other hepatic focal lesions in high risk patients. Patients and methods: This study was designed in a retrospective pattern. It included eighty five high risk patients for hepatocellular carcinoma who had undergone dynamic MRI scans. Dynamic MRI scans were evaluated using LI-RADS features for distinguishing hepatocellular carcinoma from other hepatic focal lesions. Eventually, the obtained results were correlated with serial imaging follow - up or histopathological diagnosis as the diagnostic standard of reference. Results: The majority of the included patients were found to have malignant lesions (67.1%) predominantly HCC (45.9%), followed by cholangiocarcinoma (8.2%) and finally hepatic deposits (7.1%). Considering LI-RADS categorization, hemangioma was most common among LIRAD1 group (60%), regeneration nodule among LIRAD 2 group (88.9%), dysplastic nodule among both LIRAD3 (50%) and LIRAD 4 groups (55.6). HCC among LIRAD5 group (100%). Finally, cholangiocarcinoma among LRM group (53.8 %). Conclusions: Employing LI-RADS on dynamic MRI scans for distinguishing hepatocellular carcinoma from other hepatic focal lesions in high risk patients improves patient management
应用li - rad动态mri扫描鉴别高危患者肝细胞癌与其他肝局灶性病变
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信